Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation

Journal of Controlled Release

Volumn 99, Issue 3, 2004, Pages 393-402

  Murthy, S Narasimha ^a   Zhao, Ya Li ^a   Sen, Arindam ^a   Hui, Sek Wen ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

cyclodextrin; Carboxyfluorescein; Cyclodextrin; Electroporation; Hydroxypropyl cyclodextrin; Piroxicam; Porcine epidermis; Sustained release

Indexed keywords

ELECTROPORATION; PASSIVE TRANSPORT;

ABSORPTION; HYDROPHILICITY; SUSPENSIONS (FLUIDS);

ORGANIC COMPOUNDS;

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; CARBOXYFLUORESCEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; SOLVABLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG ELIMINATION; DRUG TRANSPORT; ELECTROPORATION; EPIDERMIS; HYDROPHILICITY; MOUSE; NONHUMAN; PASSIVE TRANSPORT; PRIORITY JOURNAL;

ADMINISTRATION, CUTANEOUS; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL TRANSPORT; DIFFUSION; DRUG CARRIERS; ELECTROPORATION; FLUORESCEINS; PIROXICAM; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS; SWINE;

EID: 4644290585     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.07.026     Document Type: Article

References (27)

1. R.A. Rajewski, and V.J. Stella Pharmaceutical applications of cyclodextrins: 2. In vivo drug delivery J. Pharm. Sci. 85 1996 1142 1169
2. R.F.V. Lopez, J.H. Collett, M. Vitoria, and L.B. Bentley Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone Int. J. Pharm. 200 2000 127 132
3. U. Vollmer, B.W. Muller, J. Mesens, B. Wilfert, and T. Peters In vivo skin pharmacokinetics of liarozole: percutaneous absorption studies with different formulations of cyclodextrin derivative in rats Int. J. Pharm. 99 1993 51 58
4. M. Másson, T. Loftsson, G. Másson, and E. Stefánsson Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing J. Control. Release 59 1999 107 118
5. M. Vitroria, L.B. Bentley, R.F. Vianna, S. Wilson, and J.H. Collett Characterization of the influence of some cyclodextrins on the stratum corneum from the hairless mouse J. Pharm. Pharmacol. 49 1997 397 402
6. Y.A. Chizmadhev, A.V. Indenborn, P.I. Kuzmin, S.V. Galichenko, J.C. Weaver, and R.O. Potts Electrical properties of skin at moderate voltages: contribution of appendeageal macropores Biophys. J. 74 1998 843 856
7. R. Vanbever, E.L. Boulenge, and V. Preat Transdermal delivery of fentanyl by electroporation: I. Influence of electrical factors Pharm. Res. 13 1996 1360 1366
8. D. Bommannan, J. Tamada, L. Leung, and R.O. Potts Effect of electroporation on transdermal iontophoretic delivery of luteinizing harmone releasing harmone in vitro Pharm. Res. 11 1994 1809 1814
9. T. Zwert, U. Pliquett, R. Langer, and J.C. Weaver Transdermal transport of DNA antisense oligonucleotides by electroporation Biochim. Biophys. Acta 212 1995 286 292
10. M.R. Prausnitz, E.R. Edelman, J.S. Gimm, R. Langer, and J.C. Weaver Transdermal delivery of heparin by skin electroporation Biotechnology 13 1995 205 1209
11. U. Pliquett, R. Langer, and J.C. Weaver Changes in the passive electrical properties of human stratum corneum due to electroporation Biochim. Biophys. Acta 1239 1995 111 121
12. A. Sen, Y. Zhao, L. Zhang, and S.W. Hui Enhanced transdermal transport by electroporation using anionic lipids J. Control. Release 82 2002 399 405
13. A. Sen, Y.L. Zhao, and S.W. Hui Saturated anionic phospholipids enhance transdermal transport by electroporation Biophys. J. 83 2002 2064 2073
14. T.E. Zewert, U.F. Pliquett, R. Vanbever, R. Langer, and J.C. Weaver Creation of transdermal pathways for macromolecule transport by skin electroporation and a low toxicity, pathway-enlarging molecule Bioelectrochem. Bioenerg. 49 1999 11 20
15. A. Doliwa, S. Santoyo, and P. Ygartua Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam Int. J. Pharm. 229 2001 37 44
16. M. Makela, T. Korpela, and S. Laakso Colorimetric determination of β-cyclodextrin: two assay modifications based on molecular complexation of phenolpthtalein J. Biochem. Biophys. Methods 14 2 1987 85 92
17. G. Cevc, and G. Blume New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes Biochim. Biophys. Acta 1514 2001 191 205
18. J. Hadgraft, J. du Plessis, and C. Goosen The selection of non-steroidal anti-inflammatory agents for dermal delivery Int. J. Pharm. 207 2000 31 37
19. V. Tantishaiyakul, N. Kaewnopparat, and S. Ingkatawornwong Properties of solid dispersions of piroxicam in polyvinylpyrrolidone Int. J. Pharm. 181 1999 143 151
20. T. Loftsson, B.J. Olafsdottir, and N. Bodor The effects of cyclodextrins on transdermal delivery of drugs Eur. J. Pharm. Biopharm. 37 1 1991 30 33
21. K. Hanna, C. de Brauer, and P. Germain Solubilization of the neutral charged forms of 2,4,6-trichlorophenol by β-cyclodextrin, methyl β cyclodextrin and hydroxypropyl-β-byclodextrin in water J. Hazard. Mater., B 100 2003 109 116
22. T. Imai, T. Irie, M. Otagiri, and K. Uekama "Abstracts" Third International Symposium on Clathrate Compounds: Tokyo, Japan Abstract 1984 115 116
23. B.W. Muller, and U. Brauns Hydroxypropyl β cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity J. Pharm. Sci. 75 6 1986 571 572
24. K.S. Estes, M.E. Brewster, A.I. Webb, and N. Bodor A non-surfactant formulation for alfaxalone based on an amorphous cyclodextrin: activity studies in rats and dogs Int. J. Pharm. 65 1990 101 107
25. S.G. Woolfrey, G. Taylor, I.W. Kellaway, and A. Smith Disposition of carboxyfluorescein in the rat Int. J. Pharm. 26 1985 35 43
26. M. Helena, C. Morques, J. Hadgraft, I.W. Kellaway, and G. Taylor Studies of cyclodextrin inclusion complexes: IV. The pulmonary absorption of salbutamol from a complex with 2 hydroxypropyl-β-cyclodextrin in rabbits Int. J. Pharm. 77 1991 303 307
27. H. Reithmeier, J. Herrmann, and A. Göpferich Lipid microparticles as a parenteral controlled release device for peptides J. Control. Release 73 2001 339 350